Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Primary Immunodeficiency (PID)
Interventions
BIOLOGICAL

IgPro20

Trial Locations (13)

3010

Study Site, Bern

13353

Study Site, Berlin

41013

Study Site, Seville

41685

Study Site, Gothenburg

55131

Study Site, Mainz

75743

Study Site, Paris

79095

Study Site, Freiburg im Breisgau

300011

Study Site, Timișoara

400162

Study Site, Cluj-Napoca

04129

Study Site, Leipzig

Unknown

Study Site, Warsaw

08036

Study Site, Barcelona

EC1A7BE

Study Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY